Ha-rasVal12Oncogene Increases Susceptibility of NIH/3T3 Cells to Lovastatin
- 9 July 1998
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 248 (1), 62-68
- https://doi.org/10.1006/bbrc.1998.8911
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Enhancement of paclitaxel activity against hormone-refractory prostate cancer cells in vitro and in vivo by quinacrineBritish Journal of Cancer, 1997
- The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal.Genes & Development, 1997
- Mitogenic Signaling Mediated by Oxidants in Ras-Transformed FibroblastsScience, 1997
- Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKBNature, 1997
- Ras-mediated cell proliferation and cell death: some clues from the interleukin-2 receptor systemApoptosis, 1996
- Fibroblast Growth Factor-2 Suppression of Tumor Necrosis Factor α-Mediated Apoptosis Requires Ras and the Activation of Mitogen-activated Protein KinaseJournal of Biological Chemistry, 1996
- Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosisNature, 1996
- Lovastatin Inhibits Proliferation and Differentiation and Causes Apoptosis in Lipopolysaccharide-Stimulated Murine B CellsBiochemical and Biophysical Research Communications, 1995
- Tumor resistance to oxidative stress: Association with ras oncogene expression and reversal by lovastatin, an inhibitor of p21ras isoprenylationInternational Journal of Cancer, 1995
- Lovastatin Induces Growth Inhibition and Apoptosis in Human Malignant Glioma CellsBiochemical and Biophysical Research Communications, 1994